EUVIMEDOdkrijte EUVIMED
VergleichsstudieOpen access · CC BY 4.0

Transcriptomic comparative study between canalicular adenoma and HMGA2 :: WIF1 canalicular‐like pleomorphic adenoma

Ziyad Alsugair, Anne Champagnac, Maxime Fieux iD, Pierre Philouze, Philippe Ceruse, Brice Thamphya, Daniel Pissaloux, Franck Tirode iD, Nazim Benzerdjeb iD

The Journal of Pathology · 2026-08 · 269 (4-5) · 423-432

DOI: 10.1002/path.70070 ↗

At a glance

Vergleichsstudie in The Journal of Pathology, published online on 2026-04-29. Written by Ziyad Alsugair and 8 co-authors. Institution: Service d'Anatomie et Cytologie Pathologiques, Institut de Pathologie Multisite, Hospices Civils de Lyon, CHU Lyon Sud, Pierre-Bénite, France. Major MEDLINE topics: HMGA2 Protein, Adenoma, Pleomorphic, Biomarkers, Tumor, Salivary Gland Neoplasms. Cited 1 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Centre de Ressources Biologiques-HCL Lyon Sud.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Canalicular adenoma (CA) is a benign salivary gland tumor predominantly affecting the upper lip and is characterized by monomorphic epithelial cells arranged in branching cords within a loose and vascularized stroma. Unlike pleomorphic adenoma (PA), CA lacks a chondroid matrix and exhibits specific histological features, such as high cuboidal to columnar cells arranged in one to two cell layers. A recently identified PA subtype, named ‘ HMGA2 ‐canalicular‐like PA’, mimics the morphology of CA but affects major salivary glands, and harbors the HMGA2 :: WIF1 fusion. Immunohistochemical markers including SOX10 positivity and p40/p63 negativity are shared between these entities, raising questions about their molecular differences. Therefore, the current study aimed to extensively compare the molecular profiles of CAs and HMGA2 ‐canalicular‐like PAs to better understand the mechanisms underlying their oncogenesis. In the present study, CAs and the HMGA2 ‐canalicular‐like PAs mostly shared similar histology and immunostaining, while the clinical presentations regarding tumor site and transcriptomic profiles were different. A novel finding was the overexpression of SOX2 in patients diagnosed with CA, in comparison to those diagnosed with HMGA2 ‐canalicular‐like PA. The CAs displayed significantly higher enrichment of hallmarks for Hedgehog signaling, IL2/STAT5 signaling, and apical surface, and significantly lower enrichment of hallmarks for apoptosis and mitotic spindle. Additionally, Gene Ontology enrichment analysis displayed significant enrichment of biological process for CAs in comparison to HMGA2 ‐canalicular‐like PAs for myofibril assembly, muscle filament sliding, actin–myosin filament sliding, and sarcomere organization. CAs and HMGA2 ‐canalicular‐like PAs exhibited similar histology and immunostaining but differed significantly in tumor site and transcriptomic profiles. The latter revealed significant activation of muscle‐related transcriptional pathways, and overexpression of SOX2 in CAs. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

HMGA2 ProteinAdenoma, PleomorphicBiomarkers, TumorSalivary Gland NeoplasmsTranscriptomeAdenomaHumansFemaleMaleMiddle AgedAdultGene Expression ProfilingAged

Author keywords

HMGA2::WIF1SOX2biomarkerscanalicular adenomacanalicular‐like pleomorphic adenomaclassificationhead and neck pathologysalivary gland tumortranscriptomic analysis

Substances

HMGA2 ProteinHMGA2 protein, humanBiomarkers, Tumor

Authors and institutions

  • Service d'Anatomie et Cytologie Pathologiques, Institut de Pathologie Multisite, Hospices Civils de Lyon, CHU Lyon Sud, Pierre-Bénite, France.
  • Département de Biopathologie, Centre Leon Berard, Lyon, France.
  • Service of Oto-Rhino-Laryngology, CHU Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Université Claude Bernard Lyon 1, Lyon, France.
  • Service d'Oto-Rhino-Laryngologie et Chirurgie Cervico-Faciale, Hôpital La Croix Rousse, Hospices Civils de Lyon, Lyon, France.
  • Team Genetics, Epigenetics and Biology of Sarcomas, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 - CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.

ORCID profiles: Maxime Fieux, Franck Tirode, Nazim Benzerdjeb

Funding

  • Centre de Ressources Biologiques-HCL Lyon Sud

Cite

APA

Alsugair, Z., Champagnac, A., Fieux, M., Philouze, P., Ceruse, P., Thamphya, B., Pissaloux, D., Tirode, F., & Benzerdjeb, N. (2026). Transcriptomic comparative study between canalicular adenoma and HMGA2 :: WIF1 canalicular‐like pleomorphic adenoma. The Journal of Pathology, 269(4-5), 423-432. https://doi.org/10.1002/path.70070

Vancouver

Alsugair Z, Champagnac A, Fieux M, Philouze P, Ceruse P, Thamphya B, et al. Transcriptomic comparative study between canalicular adenoma and HMGA2 :: WIF1 canalicular‐like pleomorphic adenoma. The Journal of Pathology. 2026;269(4-5):423-432. doi:10.1002/path.70070

BibTeX
@article{Alsugair2026,
  author = {Alsugair, Ziyad and Champagnac, Anne and Fieux, Maxime and Philouze, Pierre and Ceruse, Philippe and Thamphya, Brice and Pissaloux, Daniel and Tirode, Franck and Benzerdjeb, Nazim},
  title = {Transcriptomic comparative study between canalicular adenoma and HMGA2 :: WIF1 canalicular‐like pleomorphic adenoma},
  journal = {The Journal of Pathology},
  year = {2026},
  volume = {269},
  number = {4-5},
  pages = {423--432},
  doi = {10.1002/path.70070}
}
Start for free →